Suspected Substandard Deekins Amoxycillin 500mg Capsule
The National Agency for Food and Drugs Administration and Control (NAFDAC) is investigating a case of suspected substandard Deekins Amoxycillin 500mg Capsule, manufactured by Ecomed Pharma Ltd and marketed by Devine Kings Pharmaceutical Ltd, with lot number 4C639001. This investigation stemmed from reports of serious adverse drug reactions being experienced by patients that took the medication […]
Public Alert No. 049/2024 -Sales and Distribution of Confirmed Counterfeit Paludex (Artemether/Lumefantrine ) Tablets (80mg/480mg) and Suspension (20mg/120mg)
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public about the sales and distribution of confirmed counterfeit Paludex tablets and suspensions in Nigeria. The Paludex (Artemether/Lumefantrine) tablets (80mg/480mg) are labeled manufactured by Impact Pharmaceutical Ltd, No. 33A/33B Standard Industrial Layout Emene- Enugu State, Nigeria and marketed by MD Life […]
Public Alert No. 048/2024 -Alert on Recall of Deekins Amoxycillin 500mg Capsule Batch 4C639001
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of the recall of one batch of Deekins Amoxycillin 500mg Capsule, manufactured by Ecomed Pharma Ltd and marketed by DevineKings Pharmaceutical Ltd, with lot number 4C639001. This drug batch is being recalled following reports of serious adverse drug reactions. According […]
Public Alert No. 047/2024 -Alert Recall Of Acetazolamide Tablets Usp 125mg, Manufactured By Rubicon Research Private Ltd
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of the recall of Acetazolamide Tablets usp 125mg manufactured by an American pharmaceutical company, Rubicon Research Private Ltd, with batch number 30575HF1. The company recalled the affected lot due to contamination, dirty and discoloured tablets. Acetazolamide is a potent carbonic […]
Public Alert No. 046/2024 -Alert on Recall of Two Batches of Pantogen Injection “Singtong” by Taiwanese FDA
The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying the healthcare providers of the recall of two (2) batches of Pantogen Injection “Sintong” by the Taiwanese FDA, with (Lot numbers 4DM1150 and 4DM0442), produced by Xindong Biotech Co. Ltd. The recall was initiated by the manufacturer following received customer complaints of […]
Public Alert No. 045/2024 – Alert on the Ban of Brominated Vegetable oil (BVO) used to suspend citrus flavourings into sodas and juice drinks
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public that the U.S. Food and Drug Administration (FDA) has revoked the regulation authorizing the use of brominated vegetable oil (BVO) in food. Brominated vegetable oil, or BVO, is vegetable oil modified with bromine. It’s used to suspend citrus flavourings into sodas and […]
Public Alert No. 044/2024 – Alert on Weight Loss Products Containing Banned Substances
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public that the Malaysian Ministry of Health and Singapore Food Agency (SFA), has warned against the use of three(3) food products marketed for weight loss, Lemo A Detox slimming sachets, Lemo S Detox slimming sachets, and Lemo D Detox slimming sachets. […]
Note to Industry on Requirement for Bioequivalence Study
Bioequivalence (BE) study is a clinical trial designed to demonstrate that two pharmaceutical products, typically a generic drug and its corresponding reference innovator brand have similar bioavailability and efficacy hence, interchangeable healthcare practices. Over 90% of drug products used in the country are generics with which access and affordability is created without compromising quality. Presently, […]
Danish Embassy, Danish Veterinary and Food Agency, Partner NAFDAC to Combat Antimicrobial Resistance
The National Agency for Food and Drug Administration and Control NAFDAC in its quest to safeguard the health of the nation, in partnership with the Danish Embassy held a stakeholders workshop on the dangers of Antimicrobial Resistance, AMR. The Director General of NAFDAC, Prof. Mojisola Adeyeye at the two-day workshop to celebrate the 2024 World […]
Opening Remarks by Prof. Mojisola Christianah Adeyeye, at the World Antimicrobial Awareness Week (WAAW) 2024 Titled Educate, Advocate, Act Now
Opening Remark By Prof. Adeyeye C. M Director General NAFDAC Antimicrobial Awareness Week (WAAW): Educate, Advocate, Act Now Lagos, Nigeria 21st November, 2024. PROTOCOL It is my privilege to welcome you to this year’s World Antimicrobial Awareness Week (WAAW) titled; Educate. Advocate. Act Now. This week provides the Agency an opportunity to raise awareness about […]
